ARTICLE | Distillery Techniques
Drug delivery
November 27, 2017 6:44 PM UTC
Intranasally administered albumin-based nanoparticles could deliver therapies to the brain to help treat Alzheimer's disease and other CNS diseases, bypassing the need to cross the blood-brain barrie...
BCIQ Company Profiles
BCIQ Target Profiles